vs
ExlService Holdings, Inc.（EXLS）とPediatrix Medical Group, Inc.（MD）の財務データ比較。上の社名をクリックして会社を切り替えられます
ExlService Holdings, Inc.の直近四半期売上が大きい（$542.6M vs $493.8M、Pediatrix Medical Group, Inc.の約1.1倍）。ExlService Holdings, Inc.の純利益率が高く（11.1% vs 6.8%、差は4.3%）。ExlService Holdings, Inc.の前年同期比売上増加率が高い（12.7% vs -1.7%）。過去8四半期でExlService Holdings, Inc.の売上複合成長率が高い（11.5% vs -0.1%）
ExlService Holdings Inc.は保険、ヘルスケア、銀行・金融サービス、メディア、小売などの業界を対象に分析・デジタルソリューションを提供するグローバル企業で、本社はニューヨークに所在し、米国、欧州、アジア、中南米、オーストラリア、南アフリカなど世界各地に5万4000人以上の専門スタッフを擁しています。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
EXLS vs MD — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $542.6M | $493.8M |
| 純利益 | $60.2M | $33.7M |
| 粗利率 | 38.6% | — |
| 営業利益率 | 14.4% | 9.9% |
| 純利益率 | 11.1% | 6.8% |
| 売上前年比 | 12.7% | -1.7% |
| 純利益前年比 | 18.9% | 10.5% |
| EPS（希薄化後） | $0.38 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $542.6M | $493.8M | ||
| Q3 25 | $529.6M | $492.9M | ||
| Q2 25 | $514.5M | $468.8M | ||
| Q1 25 | $501.0M | $458.4M | ||
| Q4 24 | $481.4M | $502.4M | ||
| Q3 24 | $472.1M | $511.2M | ||
| Q2 24 | $448.4M | $504.3M | ||
| Q1 24 | $436.5M | $495.1M |
| Q4 25 | $60.2M | $33.7M | ||
| Q3 25 | $58.2M | $71.7M | ||
| Q2 25 | $66.1M | $39.3M | ||
| Q1 25 | $66.6M | $20.7M | ||
| Q4 24 | $50.7M | $30.5M | ||
| Q3 24 | $53.0M | $19.4M | ||
| Q2 24 | $45.8M | $-153.0M | ||
| Q1 24 | $48.8M | $4.0M |
| Q4 25 | 38.6% | — | ||
| Q3 25 | 38.5% | — | ||
| Q2 25 | 37.7% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 38.1% | — | ||
| Q3 24 | 37.8% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 37.4% | — |
| Q4 25 | 14.4% | 9.9% | ||
| Q3 25 | 14.4% | 13.8% | ||
| Q2 25 | 15.8% | 12.8% | ||
| Q1 25 | 15.7% | 7.0% | ||
| Q4 24 | 14.8% | 7.8% | ||
| Q3 24 | 14.7% | 6.6% | ||
| Q2 24 | 13.7% | -31.3% | ||
| Q1 24 | 14.1% | 3.2% |
| Q4 25 | 11.1% | 6.8% | ||
| Q3 25 | 11.0% | 14.5% | ||
| Q2 25 | 12.8% | 8.4% | ||
| Q1 25 | 13.3% | 4.5% | ||
| Q4 24 | 10.5% | 6.1% | ||
| Q3 24 | 11.2% | 3.8% | ||
| Q2 24 | 10.2% | -30.3% | ||
| Q1 24 | 11.2% | 0.8% |
| Q4 25 | $0.38 | $0.40 | ||
| Q3 25 | $0.36 | $0.84 | ||
| Q2 25 | $0.40 | $0.46 | ||
| Q1 25 | $0.40 | $0.24 | ||
| Q4 24 | $0.31 | $0.37 | ||
| Q3 24 | $0.33 | $0.23 | ||
| Q2 24 | $0.28 | $-1.84 | ||
| Q1 24 | $0.29 | $0.05 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $328.4M | $375.2M |
| 総負債低いほど良い | $298.6M | $570.5M |
| 株主資本純資産 | $912.7M | $865.9M |
| 総資産 | $1.7B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 0.33× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $328.4M | $375.2M | ||
| Q3 25 | $390.1M | $340.1M | ||
| Q2 25 | $353.3M | $224.7M | ||
| Q1 25 | $331.4M | $99.0M | ||
| Q4 24 | $340.6M | $229.9M | ||
| Q3 24 | $325.8M | $103.8M | ||
| Q2 24 | $276.1M | $19.4M | ||
| Q1 24 | $246.2M | $8.0M |
| Q4 25 | $298.6M | $570.5M | ||
| Q3 25 | $354.8M | $577.2M | ||
| Q2 25 | $260.0M | $583.9M | ||
| Q1 25 | $307.3M | $590.5M | ||
| Q4 24 | $288.5M | $597.1M | ||
| Q3 24 | $344.7M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $912.7M | $865.9M | ||
| Q3 25 | $952.4M | $890.7M | ||
| Q2 25 | $1.1B | $833.8M | ||
| Q1 25 | $1.0B | $789.2M | ||
| Q4 24 | $929.9M | $764.9M | ||
| Q3 24 | $907.6M | $732.5M | ||
| Q2 24 | $852.6M | $706.5M | ||
| Q1 24 | $803.3M | $856.2M |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.7B | $2.2B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.7B | $2.0B | ||
| Q4 24 | $1.6B | $2.2B | ||
| Q3 24 | $1.6B | $2.1B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.4B | $2.2B |
| Q4 25 | 0.33× | 0.66× | ||
| Q3 25 | 0.37× | 0.65× | ||
| Q2 25 | 0.25× | 0.70× | ||
| Q1 25 | 0.30× | 0.75× | ||
| Q4 24 | 0.31× | 0.78× | ||
| Q3 24 | 0.38× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $117.4M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $106.5M | — |
| FCFマージンFCF / 売上 | 19.6% | — |
| 設備投資強度設備投資 / 売上 | 2.0% | — |
| キャッシュ転換率営業CF / 純利益 | 1.95× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | $298.1M | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $117.4M | $114.1M | ||
| Q3 25 | $120.7M | $137.3M | ||
| Q2 25 | $109.4M | $137.2M | ||
| Q1 25 | $3.2M | $-117.5M | ||
| Q4 24 | $105.3M | $133.0M | ||
| Q3 24 | $110.1M | $91.8M | ||
| Q2 24 | $74.9M | $107.0M | ||
| Q1 24 | $-21.9M | $-125.2M |
| Q4 25 | $106.5M | — | ||
| Q3 25 | $106.4M | — | ||
| Q2 25 | $95.0M | — | ||
| Q1 25 | $-9.7M | — | ||
| Q4 24 | $95.3M | — | ||
| Q3 24 | $97.3M | — | ||
| Q2 24 | $62.8M | — | ||
| Q1 24 | $-33.1M | — |
| Q4 25 | 19.6% | — | ||
| Q3 25 | 20.1% | — | ||
| Q2 25 | 18.5% | — | ||
| Q1 25 | -1.9% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 20.6% | — | ||
| Q2 24 | 14.0% | — | ||
| Q1 24 | -7.6% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 2.6% | — | ||
| Q4 24 | 2.1% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 2.7% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | 1.95× | 3.39× | ||
| Q3 25 | 2.08× | 1.91× | ||
| Q2 25 | 1.66× | 3.49× | ||
| Q1 25 | 0.05× | -5.66× | ||
| Q4 24 | 2.08× | 4.36× | ||
| Q3 24 | 2.08× | 4.72× | ||
| Q2 24 | 1.63× | — | ||
| Q1 24 | -0.45× | -31.03× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
EXLS
| Insurance | $185.8M | 34% |
| Healthcare And Life Sciences | $142.2M | 26% |
| Banking Capital Markets And Diversified Industries | $122.6M | 23% |
| International Growth Markets | $92.0M | 17% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
